Suraksha Diagnostic Limited (SURAKSHA) Share Price
NSE · Healthcare · Diagnostics & Research · ISIN INE877V01027
Key metrics
- Market Cap
- ₹1,769 Cr
- P/E Ratio
- 49.36
- EPS
- 6.88
- Book Value
- 46.75
- P/B Ratio
- 7.28
- ROE
- 13.22%
- ROCE
- 14.56%
- Debt / Equity
- 0.54
- Net Margin
- 10.37%
- Revenue Growth
- 23.13%
- Profit Growth
- 1.14%
- Dividend Yield
- 0.15%
- 52W High
- ₹348.95
- 52W Low
- ₹224.10
- Market Cap Band
- small cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Suraksha Diagnostic Limited
Suraksha Diagnostic Limited provides pathological and radiological services through diagnostic centers in India. It offers home collection services; pathology services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, haematology, clinical biochemistry and immunology, immunohistochemistry, fluorescence in-situ hybridization, cytogenetics, flow cytometry, newborn screening, and NGS. The company also provides microarray, QF-PCR, FISH, karyotyping, and NIPT services; X-Ray, MRI scan, CT scan, USG, DEXA scan, Mammography, OPG radiology services; ECG, echocardiogram, stress test and treadmill test, wireless holter monitoring, and PFT cardiology services; EEG, EMG, and NCV neurology services; and upper GI and lower GI endoscopy, sigmoidoscopy, proctoscopy, colonoscopy, and proctosigmoidoscopy gastroenterology services. In addition, it offers clinic services, including dental, physiotherapy, immunology and rheumatology, ENT, eye, and specialty clinics, as well as fetal care; home doctor visit services; online doctor consultation; and doctor curated lab packages for bone and health, men's and women's health, senior citizens, diabetes care, fever, full-body checkups, and at-home packages. The company was founded in 1992 and is based in Kolkata, India.
- Headquarters
- Kolkata, India
- Employees
- 1,600
- Promoter Holding
- 61.97%
The full Suraksha Diagnostic Limited analysis
Create a free account to open the complete SURAKSHA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.